Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
J Menopausal Med. 2018 Apr;24(1):1-10. English. Meta-Analysis.
Lee A , Kim TH , Lee HH , Kim YS , Enkhbold T , Lee B , Park YJ , Song K .
Department of Interdisciplinary Program in Biomedical Science, Soonchunhyang University, Asan, Korea.
Department of Obstetrics and Gynecology, Soonchunhyang University College of Medicine, Bucheon, Korea.
Department of Obstetrics and Gynecology, Etemo Clininc, Ulaanbaatar, Mongolia.
Department of Biostatistics, Graduate School of Chung-Ang University, Seoul, Korea.


Atrophic vaginitis (AV), which is common in postmenopausal women, is characterized by vaginal dryness, dyspareunia, and discomfort. There are a variety of therapeutic agents for the treatment of AV, besides hormone replacement therapy. We performed this systematic review to compare the effectiveness of various therapies for symptom improvement in AV patients.


We searched the Cochrane Library, EMBASE, MEDLINE, and other literature (Google Scholar, Web of Science, and hand search) for studies published between January 2010 and March 2015. AV was evaluated by the following outcomes: vaginal pH, dyspareunia, vaginal dryness, or cytological change (endometrial thickness, percentages of superficial cells and parabasal cells). They measured treatment efficacy with various outcomes pertaining to AV symptoms.


Meta-analysis suggested that ospemifene was effective against dyspareunia, vaginal dryness, endometrial thickness, and percentage changes in superficial and parabasal cells. Vaginal pH was most affected by soy isoflavone vaginal gel. Ospemifene was effective for AV symptoms.


This systematic review compared the effects of several therapeutic agents on symptoms of AV through a network meta-analysis. This study provides objective evidence for clinical treatment and efficacy management in AV.

Copyright © 2019. Korean Association of Medical Journal Editors.